People have nine such sodium channels in the body, and different ones ... and the company launched human studies that were completed in early 2024. Vertex submitted a request for FDA approval ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

over the next six months as part of the company's transition towards becoming a developer of therapies that edit genes within the body. December 4, 2024 CMS enters agreement with Vertex ...